⚡️💥🇺🇸#SRNE
Sorrento to Obtain Exclusive Rights in N and S Amer, Europe, Major Asian Countries, Certain Other Countries to Utilize Dyadic's C1 Technology
#DYAI Dyadic and Sorrento Announce Binding Term Sheet to License Dyadic's Lead Cvid-19 Vaccine Candidate and C1 Technology for Protein-Based Coronavirus Vaccines and Therapeutics